Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin–superoxide dismutase–catalase–carbonic anhydrase

References

• Alayash AI. 2004. Redox biology of blood. Antioxid Redox Signal. 6:941–943.
   PubMed Web of Science ®Google Scholar
• Arthurs G, Sudhakar M. 2005. Carbon dioxide transport. Continuing Education in Anaesthesia. Critical Care & Pain. 5:207–210.
   Google Scholar
• Bian Y, Rong Z, Chang TM. 2012. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Immobil Biotechnol. 40:28–37.
   PubMed Web of Science ®Google Scholar
• Bian Y, Chang TMS. 2015. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artif Cells Nanomed Biotechnol. 43:1–9.
   PubMed Web of Science ®Google Scholar
• Chang TM. 1964. Semipermeable microcapsules. Science. 146:524–525.
   PubMed Web of Science ®Google Scholar
• Chang TM. 1971. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 44:1531–1536.
   PubMed Web of Science ®Google Scholar
• Chang TM. 2007. Artificial cells: Biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation, cell/stem cell therapy. World Scientific Publisher/Imperial College Press, p. 455. Available at http://www.medicine.mcgill.ca/artcell/2007%20ebook%20artcell%20web.pdf. Accessed on April 2 2015.
   Google Scholar
• Chang TM. 2012. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond. Artif Cells Blood Substit Immobil Biotechnol. 40:197–199.
   PubMed Web of Science ®Google Scholar
• Chang TM. 2013. Selected topics in nanomedicine. In: Chang TMS, Ed. Artificial cells that started nanomedicine. World Science Publisher/Imperial College Press, pp. 1–21.
   Google Scholar
• Crowell AM, Wall MJ, Doucette AA. 2013. Maximizing recovery of water-soluble proteins through acetone precipitation. Anal Chim Acta. 796:48–54.
   PubMed Web of Science ®Google Scholar
• da Costa Ores J, Sala L, Cerveira GP, Kalil SJ. 2012. Purification of carbonic anhydrase from bovine erythrocytes and its application in the enzymic capture of carbon dioxide. Chemosphere. 88:255–259.
   PubMed Web of Science ®Google Scholar
• D’Agnillo F, Chang TM. 1998. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol. 16:667–671.
   PubMed Web of Science ®Google Scholar
• Foulkes E, Lemberg R. 1949. The formation of choleglobin and the role of catalase in the erythrocyte. Proceedings of the Royal Society of London. Series B-Biological Sciences. 136:435–448.
   Google Scholar
• Geers C, Gros G. 2000. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev. 80:681–715.
   PubMed Web of Science ®Google Scholar
• Gu J, Chang TM. 2009. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase. Artif Cells Blood Substit Immobil Biotechnol. 37:69–77.
   PubMed Web of Science ®Google Scholar
• Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. 2008. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma. 64:1484–1497.
   PubMed Web of Science ®Google Scholar
• Kim HW, Greenburg AG (Eds.). 2014. Hemoglobin-based oxygen carriers as red cell substitutes and oxygen therapeutics. Springer.
   Google Scholar
• Magner E, Klibanov AM. 1995. The oxidation of chiral alcohols catalyzed by catalase in organic solvents. Biotechnology Bioeng. 46:175–179.
   PubMed Web of Science ®Google Scholar
• Miller H. 1958. The relationship between catalase and haemoglobin in human blood. Biochem J. 68:275–282.
   PubMedGoogle Scholar
• Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB. 2009. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 208:1–13.
   PubMed Web of Science ®Google Scholar
• Paco L, Galarneau A, Drone J, Fajula F, Bailly C, Pulvin S, Thomas D. 2009. Catalase‐like activity of bovine met‐hemoglobin: interaction with the pseudo‐catalytic peroxidation of anthracene traces in aqueous medium. Biotechnol J. 4:1460–1470.
   PubMedGoogle Scholar
• Powanda DD, Chang TM. 2002. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artif Cells Blood Substit Immobil Biotechnol. 30:23–37.
   PubMed Web of Science ®Google Scholar
• Sims C, Seigne P, Menconi M, Monarca J, Barlow C, Pettit J, Puyana JC. 2001. Skeletal muscle acidosis correlates with the severity of blood volume loss during shock and resuscitation. J Trauma. 51:1137–1145; discussion 1145–1146.
   PubMed Web of Science ®Google Scholar
• Ugwu SO, Apte SP. 2004. The effect of buffers on protein conformational stability. Pharm Technol. 28:86–109.
   Google Scholar
• Zhu H, Du Q, Chen C, Chang TM. 2010. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate. Artif Cells Blood Substit Immobil Biotechnol. 38:57–63.
   PubMed Web of Science ®Google Scholar